HRTX FY 2011 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$152M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$646,000-50.3% YoY

Gross Profit

$467,00072.3% margin

Operating Income

-$11M-1712.4% margin

Net Income

-$12M-1828.8% margin

EPS (Diluted)

$-1.18

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$19M

Total Liabilities

$4M

Stockholders' Equity

$16M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$646,000	$1M	-50.3%
Gross Profit	$467,000	$1M	-64.1%
Operating Income	-$11M	-$10M	-11.4%
Net Income	-$12M	-$7M	-60.8%